Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5d1de0cb099ee72980dadb3b90d66d8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1051 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 |
filingDate |
2002-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71c7bd0f7ace718bbd80aee783fe7d7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78f1df92b739b48cbc8427a51cab6d29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b22aa4a15730cc9ea99dfdd967bc2af6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2e36efd88b1e8b7b9935e0316bfa03d |
publicationDate |
2003-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2003175922-A1 |
titleOfInvention |
Beta-1,3-galactosyltransferase homologs |
abstract |
The present invention relates to polynucleotide and polypeptide molecules for znssp2, a novel member of the galactosyltransferase family. The polypeptides, and polynucleotides encoding them, are cell-cell interaction and glycoprotein synthesis modulating and may be used for delivery and therapeutics. The present invention also includes antibodies to the znssp2 polypeptides. |
priorityDate |
1998-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |